DR.REDDY'S LABORATORIESPharmaceuticalsINE089A01031Consolidated₹1374.00+5.70 (+0.42%)
Valuation
Market Cap₹1.15L Cr
TTM PE40.89x
Forward PE54.04x
PEG-3.11
Book Value₹464.94
P/B2.96x
TTM EPS₹33.60
Fwd EPS₹25.43
TTM Revenue₹33.10K Cr
TTM PAT₹2.76K Cr
TTM EBITDA₹4.86K Cr
TTM EBIT₹2.72K Cr
Last Qtr PAT₹913.20 Cr
Last Qtr EBITDA₹1.73K Cr
Last Qtr EBIT₹1.20K Cr
Profitability
ROE7.11%
ROCE8.63%
TTM NPM8.34%
TTM EBITDA %14.69%
Curr OPM10.31%
Last OPM5.15%
Curr NPM—
Last NPM—
Curr EPS₹11.09
Last EPS₹5.33
Balance sheet
Equity₹83.50 Cr
Reserve₹38.72K Cr
Total Debt₹7,228.70 Cr
D/E0.19x
Interest %13.67%
Curr Interest₹124.80 Cr
Price / range
Close₹1374.00
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+0.42%
1W+2.89%
1M+13.91%
3M+17.18%
6M+6.74%
1Y+14.42%
2Y+8.36%
3Y+30.58%
5Y+44.14%
Diwali+9.60%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1773.40₹4.25L Cr38.8112.31%
DIVISLAB10037.50₹2.66L Cr91.0817.45%
TORNTPHARM4738.50₹1.60L Cr77.7711.42%
LAURUSLABS2323.80₹1.25L Cr93.6321.98%
ZYDUSLIFE1188.10₹1.20L Cr28.5315.79%
DRREDDY1374.00₹1.15L Cr40.897.11%
CIPLA1402.00₹1.13L Cr39.098.06%
MANKIND2537.90₹1.05L Cr46.7112.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue5,572.60+20.7%5,136.603,8224,282.704,618.6020,532.80
Other Income217.30440.40567.20360.30364.201,689.60
Total Income5,789.90+16.2%5,5774,389.204,6434,982.8022,222.40
Interest7773.1054.3041.4033.40148.30
Expenditure-4,888.60-9.5%-5,080-4,694.70-4,538.80-4,466.50-17,971.10
PBDT000000
EBITDA1,094.70+127.9%447.40-499.9099.60480.303,917.40
Depreciation-333.70-317.70-318.50-314.30-294.80-1,207.40
EBIT761+310.2%129.70-818.40-214.70185.502,710
PBT901.30+74.6%497-305.50104.20516.304,251.30
Tax-205.50-92.3086.10-13.60-129-1,031.60
Equity83.5083.5083.500083.50
OPM15.578.91-6.962.4311.1819.13
Net Profit695.80+79.7%404.70-219.4090.60387.303,219.70
NPM12.027.26-5.002.128.3914.49
EPS0-100.0%4.86-2.631.094.6538.68

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue20,532.80-11.2%23,115.40+18.6%19,483.80+14.9%16,962.50+17.8%14,405.20+7.9%13,349.10
Other Income1,689.601,003.40862.30591.30482801.10
Total Income22,222.40-7.9%24,118.80+18.5%20,346.10+15.9%17,553.80+17.9%14,887.20+5.2%14,150.20
Expenditure-17,971.10-6.4%-16,882.90-16.0%-14,554.80-6.3%-13,687.80-8.1%-12,663.40-14.1%-11,094
Interest-148.30-109.90-21.80-16.90-38-46.70
PBDT000000
EBITDA3,917.40-46.9%7,381.80+24.6%5,926.40+40.6%4,214.80+62.5%2,594.10-17.3%3,136.80
Depreciation-1,207.40-1,039.40-975.60-923.20-814.30-835
EBIT2,710-57.3%6,342.40+28.1%4,950.80+50.4%3,291.60+84.9%1,779.80-22.7%2,301.80
PBT4,251.30-41.2%7,235.90+24.9%5,791.30+49.8%3,866+73.8%2,223.80-27.2%3,056.20
Tax-1,031.60-1,886.50-1,449.30-1,253.20-600.60-869.80
Equity83.5083.400000
OPM (%)19.1330.0028.0022.0015.0022.00
Net Profit3,219.70-39.8%5,349.40+23.2%4,342+66.2%2,612.80+61.0%1,623.20-25.8%2,186.40
NPM (%)14.4922.1821.0015.0011.0015.00
EPS (Rs)38.68-39.8%64.22-75.4%260.95+65.8%157.37+60.8%97.85-25.8%131.84
CEPS38.6464.13260.46157.0397.58131.46

Consolidated

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue8,697.80-1.5%8,099.807,546.408,753.408,828.3033,700.20
Other Income156.20354.70475.40268.80323.901,358.40
Total Income8,854-3.3%8,454.508,021.809,022.209,152.2035,058.60
Interest124.80125.50105.7094.4090.70373.80
Expenditure-7,618.70-2.8%-7,902-7,826.70-7,481.30-7,413.70-29,679.30
PBDT000000
EBITDA1,730.60-13.9%859.90382.501,887.502,009.906,453.50
Depreciation-526.70-536.60-557.10-521-504.60-2,058.80
EBIT1,203.90-20.0%323.30-174.601,366.501,505.304,394.70
PBT1,235.30-28.9%552.50195.101,540.901,738.505,379.30
Tax-314.40-117.7021.60-353.60-408-1,235.10
Equity83.5083.5083.500083.50
OPM13.956.532.4317.0819.0015.34
Net Profit913.20-31.7%435.60221.301,189.601,336.804,157.60
NPM10.315.152.7613.1914.6111.86
EPS11.09-31.5%5.332.6514.5316.1850.41

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue33,700.20+3.2%32,643.90+16.5%28,011.10+13.5%24,669.70+14.5%21,545.20+13.1%19,047.50
Other Income1,358.401,097.30894.301,055.50484.40291.40
Total Income35,058.60+3.9%33,741.20+16.7%28,905.40+12.4%25,725.20+16.8%22,029.60+13.9%19,338.90
Expenditure-29,679.30-13.8%-26,083.40-20.1%-21,719.10-10.2%-19,713.70-3.5%-19,038.50-15.4%-16,503.40
Interest-373.80-282.90-171.10-142.80-95.80-97
PBDT000000
EBITDA6,453.50-24.5%8,547.10+7.7%7,933.10+25.0%6,349+68.5%3,767.70-2.6%3,869.90
Depreciation-2,058.80-1,703.70-1,470-1,250.20-1,165.20-1,228.80
EBIT4,394.70-35.8%6,843.40+5.9%6,463.10+26.8%5,098.80+95.9%2,602.50-1.5%2,641.10
PBT5,379.30-29.8%7,657.80+6.6%7,186.30+19.5%6,011.50+101.0%2,991.10+5.5%2,835.50
Tax-1,235.10-1,954.30-1,623.10-1,541.20-878.90-931.90
Equity83.5083.400000
OPM (%)15.3422.7024.8623.3713.5814.66
Net Profit4,157.60-27.4%5,725.20+2.6%5,577.90+23.8%4,507.30+106.5%2,182.50+11.8%1,951.60
NPM (%)11.8616.9719.3017.529.9110.09
EPS (Rs)50.41-25.7%67.89-79.7%335.22+23.5%271.47+106.3%131.57+11.8%117.67
CEPS50.3567.79334.59270.90131.21117.34

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

19
YearTypeAmountEx-Date
2026Final Dividend810 Jul 2026
2025Final Dividend810 Jul 2025
2024Final Dividend4016 Jul 2024
2023Final Dividend4011 Jul 2023
2022Final Dividend3011 Jul 2022
2021Final Dividend2509 Jul 2021
2020Final Dividend2513 Jul 2020
2019Final Dividend2015 Jul 2019
2018Final Dividend2016 Jul 2018
2017Final Dividend2017 Jul 2017
2016Final Dividend2018 Jul 2016
2015Final Dividend2010 Jul 2015
2014Final Dividend1811 Jul 2014
2013Final Dividend1512 Jul 2013
2012Final Dividend13.7528 Jun 2012
2011Final Dividend11.2530 Jun 2011
2010Final Dividend11.2502 Jul 2010
2009Final Dividend6.2503 Jul 2009
2008Final Dividend3.7504 Jul 2008

Bonus

0

No bonus history.

Split

1
YearRatioEx-Date
2024Rs.5/- to Rs.1/-28 Oct 2024
Loading company dashboard...
Fetching ratios, charts, and peers